How Low-Dose Atropine Slows Myopia
Atropine is a well-established pharmaceutical agent that has been used in ophthalmology for over a century. At very low concentrations (0.025 to 0.05 percent), atropine has been shown to slow axial elongation of the eye — the structural change that drives myopia progression — with minimal impact on pupil size or near focusing ability.
The exact mechanism is still being studied, but current evidence suggests that low-dose atropine acts on muscarinic receptors in the sclera and choroid, modulating biochemical signals that regulate eye growth. The landmark ATOM and LAMP studies — conducted over multiple years with thousands of children — established that concentrations between 0.025 and 0.05 percent provide meaningful slowing with the best side-effect profile.
Dr. Patel selects the atropine concentration based on your child's age, current prescription, rate of progression, and whether other myopia control treatments are already in place. Dosing can be titrated up or down over time based on treatment response.
Combination power: Low-dose atropine is frequently paired with ortho-k or MiSight for children whose myopia is progressing aggressively — delivering additive slowing that neither treatment achieves alone.
Why Atropine Therapy
Advantages of Low-Dose Atropine
One Drop at Bedtime
The simplest possible routine — one drop in each eye before sleep. No lenses to insert, remove, or clean.
Backed by Major Studies
The ATOM and LAMP trials provide robust, multi-year evidence for atropine's safety and efficacy in children.
Ideal for Combination
Easily paired with ortho-k, MiSight, or Stellest lenses for enhanced myopia control in fast progressors.
Youngest Patients Welcome
Can be prescribed for children as young as 4-5 — before they are ready for contact lenses.
Minimal Side Effects
At 0.025-0.05% concentration, most children experience no noticeable pupil dilation or near-vision blur.
Adjustable Dosing
Concentration can be titrated from 0.025% to 0.05% based on your child's response and progression rate.
Why Choose PersonalEyes for Atropine Therapy
Statewide Myopia Lecturer
Dr. Kumar Patel, Diplomate of the American Board of Optometry, lectures across Texas on myopia control and prism therapy.
Data-Driven Dosing
We use axial length biometry and cycloplegic refraction to objectively guide atropine concentration decisions.
Full Treatment Arsenal
If atropine alone is insufficient, we seamlessly add ortho-k, MiSight, or Stellest lenses for combination therapy.
Conveniently located at 2600 Lakeside Parkway, Suite 180, Flower Mound, TX 75022 — proudly serving Flower Mound, Highland Village, Lewisville, Grapevine, Coppell, Lantana, Argyle, and the greater DFW area.
Frequently Asked Questions
Low-Dose Atropine FAQ
Clinical Evidence & Sources
- Yam JC, et al. Low-Concentration Atropine for Myopia Progression (LAMP) Study. Ophthalmology. 2019;126(1):113-124.
- Individual results vary by concentration, age, and treatment duration.
